Lasset C - Search Results

1

CD44--a new prognostic marker for neuroblastoma.

Favrot MC, Combaret V, Lasset C. Favrot MC, et al. Among authors: lasset c. N Engl J Med. 1993 Dec 23;329(26):1965. doi: 10.1056/NEJM199312233292615. N Engl J Med. 1993. PMID: 7504209 No abstract available.

2

Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.

Combaret V, Gross N, Lasset C, Balmas K, Bouvier R, Frappaz D, Beretta-Brognara C, Philip T, Favrot MC, Coll JL. Combaret V, et al. Among authors: lasset c. Br J Cancer. 1997;75(8):1151-5. doi: 10.1038/bjc.1997.198. Br J Cancer. 1997. PMID: 9099963 Free PMC article.

3

Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma.

Combaret V, Gross N, Lasset C, Frappaz D, Beretta-Brognara C, Philip T, Beck D, Favrot MC. Combaret V, et al. Among authors: lasset c. Eur J Cancer. 1997 Oct;33(12):2101-5. doi: 10.1016/s0959-8049(97)00236-0. Eur J Cancer. 1997. PMID: 9516862

4

[CD44 expression: a new prognostic factor in neuroblastoma].

Combaret V, Lasset C, Bouvier R, Frappaz D, Thiesse P, Rebillard AC, Philip T, Favrot MC. Combaret V, et al. Among authors: lasset c. Bull Cancer. 1995 Jan;82(2):131-6. Bull Cancer. 1995. PMID: 10846530 French.

5

Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors.

Combaret V, Lasset C, Frappaz D, Bouvier R, Thiesse P, Rebillard AC, Philip T, Favrot MC. Combaret V, et al. Among authors: lasset c. Eur J Cancer. 1995;31A(4):545-9. doi: 10.1016/0959-8049(95)00027-g. Eur J Cancer. 1995. PMID: 7576964

6

Indication and limits of megatherapy and bone marrow transplantation in high-risk neuroblastoma: a single centre analysis of prognostic factors.

Ladenstein R, Favrot M, Lasset C, Bouffet E, Philip I, Combaret V, Chauvin F, Brunat-Mentigny M, Biron P, Philip T. Ladenstein R, et al. Among authors: lasset c. Eur J Cancer. 1993;29A(7):947-56. doi: 10.1016/s0959-8049(05)80200-x. Eur J Cancer. 1993. PMID: 8499148

7

Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.

Combaret V, Gross N, Lasset C, Frappaz D, Peruisseau G, Philip T, Beck D, Favrot MC. Combaret V, et al. Among authors: lasset c. J Clin Oncol. 1996 Jan;14(1):25-34. doi: 10.1200/JCO.1996.14.1.25. J Clin Oncol. 1996. PMID: 8558206

8

Screening for neuroblastoma in France: methodological aspects and preliminary observations.

Chauvin F, Mathieu P, Frappaz D, Lasset C, Favrot MC, Greffe J, Esteve J, Thiesse P, Combaret V, Chauvot P, Boschetti R, David L, Brunat-Mentigny M, Philip T. Chauvin F, et al. Among authors: lasset c. Med Pediatr Oncol. 1997 Feb;28(2):81-91. doi: 10.1002/(sici)1096-911x(199702)28:2<81::aid-mpo1>3.0.co;2-o. Med Pediatr Oncol. 1997. PMID: 8986143

9

A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations.

Mathieu P, Frappaz D, Chauvin F, Combaret V, Vercherat M, Brunat-Mentigny M, David L, Esteve J, Favrot M, Fouillat V, Greffe J, Lasset C, Renaud P, Philip T. Mathieu P, et al. Among authors: lasset c. Early Hum Dev. 1996 Sep 20;46(1-2):177-96. doi: 10.1016/0378-3782(96)01763-x. Early Hum Dev. 1996. PMID: 9019414

10

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma.

Bain C, Merrouche Y, Puisieux I, Blay JY, Negrier S, Bonadona V, Lasset C, Lanier F, Duc A, Gebuhrer L, Philip T, Favrot MC. Bain C, et al. Among authors: lasset c. Br J Cancer. 1997;75(2):283-6. doi: 10.1038/bjc.1997.46. Br J Cancer. 1997. PMID: 9010039 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters